Filing Details

Accession Number:
0001209784-14-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-10 19:06:13
Reporting Period:
2014-12-08
Filing Date:
2014-12-10
Accepted Time:
2014-12-10 19:06:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1116463 Orasure Technologies Inc OSUR Surgical & Medical Instruments & Apparatus (3841) 364370966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209780 H Ronald Spair 220 East First Street
Bethlehem PA 18015
Coo & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-08 126 $5.60 164,472 No 4 M Direct
Common Stock Disposition 2014-12-08 126 $10.00 164,346 No 4 S Direct
Common Stock Acquisiton 2014-12-09 900 $5.60 165,246 No 4 M Direct
Common Stock Disposition 2014-12-09 900 $10.00 164,346 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified stock option Disposition 2014-12-08 126 $0.00 126 $5.60
Common Stock Nonqualified stock option Disposition 2014-12-09 900 $0.00 900 $5.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,561 2015-01-26 No 4 M Direct
18,661 2015-01-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 78,882 Indirect By Non-qualified Deferred Compensation Plan
Footnotes
  1. Sale pursuant to a predetermined sales plan, entered into on November 22, 2013, under Rule 10b5-1 of the Securities and Exchange Act of 1934.
  2. Nonqualified stock options granted on January 26, 2005 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.